[Rev. 11/22/2013 9:05:32
[NAC-454 Revised Date: 2-04]
CHAPTER 454 - POISONS, DANGEROUS DRUGS AND
454.010 “Board” defined.
454.030 Sale of nasal inhalers containing
stimulants to the central nervous system.
454.040 Security of drugs, chemicals,
poisons and restricted devices.
454.050 Records to be maintained by
454.060 Requirements for written
prescriptions for dangerous drugs.
NAC 454.010 “Board” defined. As used in this chapter, “Board” means the
State Board of Pharmacy.
[Bd. of Pharmacy, § 454.010, eff. 6-26-80]
NAC 454.030 Sale of nasal inhalers containing
stimulants to the central nervous system. Nasal inhalers and
preparations designed and intended to be instilled or sprayed into the
nostrils, which contain drugs capable of causing stimulation to the central
nervous system, the sale of which is not restricted to prescription only, may
be sold at retail only by a registered pharmacist when such sales are made in
good faith for medicinal use in the treatment of human illness.
[Bd. of Pharmacy, § 454.030, eff. 6-26-80]
NAC 454.040 Security of drugs, chemicals, poisons and restricted devices. Restricted
or prescription drugs, chemicals and poisons and restricted devices must be
stored within the pharmacy in such a manner and place as will make them
inaccessible to the public. The self-service display of any such drug,
chemical, poison or device is prohibited.
[Bd. of Pharmacy, part § 453.220, eff. 6-26-80]
NAC 454.050 Records to be maintained by pharmacist.
1. A pharmacist shall maintain, in
connection with any sale of supplies of dangerous drugs to a practitioner, the
order presented in connection with the purchase which contains the following
(a) The name of the practitioner, and his address
if it is not immediately available to the pharmacist.
(b) The classification of the practitioner’s
(c) The name, strength and quantity of the drug or
2. A pharmacist shall maintain the following
records in connection with any sale or replenishment of supplies of dangerous
drugs to the holder of a permit for the operation of an ambulance, air
ambulance or a vehicle of a fire-fighting agency at the scene of an emergency:
(a) The purchase order, which must contain the
(1) The name of the patient.
(2) The date of the order.
(3) The name, strength and quantity of the
(4) The number of the run of the specific
vehicle, which references the record of transport or treatment of the patient.
(b) A certification, which may be placed on the
purchase order or on a separate paper attached to the purchase order, signed by
the pharmacist filling the order and the person receiving the order and
(1) The date the order was filled by the
(2) Any deletion or change in the dangerous
drug furnished pursuant to the order; and
(3) The number of the certificate or license
of the practitioner, intermediate emergency medical technician, advanced
emergency medical technician-ambulance or registered nurse in charge of the
dangerous drug on the ambulance, air ambulance or vehicle of a fire-fighting
agency, if the number is not on file in the pharmacy.
(Added to NAC by Bd. of Pharmacy, eff. 10-17-86)
NAC 454.060 Requirements for written prescriptions for dangerous drugs. In
addition to the requirements of NRS
454.223, each written prescription for a dangerous drug must:
1. Contain the handwritten signature of the
prescribing practitioner in nonerasable ink; and
2. Be submitted to the pharmacist in its
(Added to NAC by Bd. of Pharmacy, eff. 1-10-94)